SynBioBeta Speaker
Eric Kelsic
CEO & Founder
Dyno Therapeutics
Under Eric’s leadership Dyno has raised over $100M in VC financing, including a 2021 Series A led by a16z, partnered with leading gene therapy developers including Astellas, Roche, and Sarepta, and with technology companies including NVIDIA. Prior to founding Dyno, Eric led a team to develop the technology underlying Dyno’s artificial intelligence powered capsid engineering platform in George Church’s lab at the Wyss Institute of Harvard Medical School. There he measured the first comprehensive fitness landscape of the adeno-associated virus (AAV) capsid protein and co-discovered the AAV MAAP gene. He earned a PhD in Systems Biology from Harvard University and a BS in Physics from Caltech.
SynBioBeta 2025 - Session Speaker
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Previous Speakers Include
2026
Event Updates